{
"@context": "https://schema.org",
"@type": "Article",
"headline": "OIG: Biopharma Company’s Provision of Free Genetic Tests Does Not Warrant Sanctions Under AKS",
"url": "https://www.lexblog.com/2022/05/17/oig-biopharma-companys-provision-of-free-genetic-tests-does-not-warrant-sanctions-under-aks/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-PQX26DVA",
"url": "https://www.lexblog.com/lib/PQX26DVA/"
},
"datePublished": "2022-05-17T13:37:29-04:00",
"dateModified": "2022-05-31T09:26:38-04:00",
"author": {
"@type": "Person",
"name": "Jeffrey Ehrhardt, Jeff Kaiser"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Rivkin Radler"
},
"organizationScope": "at-publication",
"isPartOf": "Rivkin Rounds",
"about": "Health Care and Life Sciences",
"sourceUrl": "https://www.rivkinrounds.com/?p=3255",
"sourceStability": "may-move"
}